About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« National Institute of Mental Health Research News | Main | Meet Miki »

April 7, 2006

Pifzer Buys Rinat Neuroscience - Neurotech M&A Remains Hot

Email This Entry

Posted by Zack Lynch

Pfizer is reportedly paying hundreds of millions of dollars for Rinat Neurosciences, a neuropharma company that has been developing therapies for pain, Alzheimer's and other neurological diseases. Terms of the deal weren't disclosed, but Pfizer has been rapidly adding to its pipeline by avidly buying up developers with promising therapies. Rinat has gained a reputation for its work on injectable protein-based therapies. The CEO of Rinat said that licensing talks turned to an offer of a buyout.

This is just another sign that a growing number of neurotech companies are going to establish their best valuation by an outright acquisition. With big pharma companies scrambling for new drugs and armed with billions of newly repatriated dollars, smaller biotech companies are looking like good investments. Add a somewhat sour market environment for IPOs and you have all the ingredients necessary for a big wave of acquisitions.

For a comprehensive analysis of neurotech M&A see the newly released Neurotechnology Industry 2006 Report.

Comments (1) + TrackBacks (0) | Category: Neurotech Industry


1. Kensai on April 8, 2006 11:05 AM writes...

Pharmaceutical companies have been quick to jump on the neurotechnology backwagon but I think we can still see more engineering [devices] companies addressing neurological maladies. Sky is the limit!


Permalink to Comment


Email this entry to:

Your email address:

Message (optional):

Chinese Cover of The Neuro Revolution
The Neuro Revolution Lands In China
How Neuroscience Will Change the World - My Interview on
Neuroscience Hearing on Capitol Hill Wednesday Sept 29, 2pm
The Neuro Revolution Published in Japan as "Neuro Wars"
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20